In Vivo Bioequivalence and In Vitro Similarity Factor (f2) for Dissolution Profile Comparisons of Extended Release Formulations: How and When Do They Match?
2011
Purpose
To investigate how likely two extended release formulations are to be bioequivalent when they demonstrate f2 similarity.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
17
References
36
Citations
NaN
KQI